New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies
Disease relapse caused by drug resistance still represents a major clinical hurdle in cancer treatments. Tumor cells may take advantage of different intracellular and genetic systems attenuating the drug effects. Resistant cells or minimal residual disease (MRD) cells have strong clinical relevance,...
Main Authors: | Giulia Mitola, Paolo Falvo, Francesco Bertolini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/11/1131 |
Similar Items
-
Rigor Me This: What Are the Basic Criteria for a Rigorous, Transparent, and Reproducible Scientific Study?
by: Brian E. Sansbury, et al.
Published: (2022-07-01) -
In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview
by: Zhiqin Li, et al.
Published: (2021-04-01) -
Animal Models for Investigating Osseointegration: An Overview of Implant Research over the Last Three Decades
by: Antonio Scarano, et al.
Published: (2024-03-01) -
Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies
by: Niege A. J. C. Furtado, et al.
Published: (2017-03-01) -
Relationship between Endotoxin Content in Vaccine Preclinical Formulations and Animal Welfare: An Extensive Study on Historical Data to Set an Informed Threshold
by: Federica Baffetta, et al.
Published: (2024-07-01)